The Vaccine: Inside the Race to Conquer the COVID-19 Pandemic

The Vaccine: Inside the Race to Conquer the COVID-19 Pandemic

光速計畫: BioNTech疫苗研發之路

出版日期:
2021/11/15
5
1,015507
查詢門市庫存

內容簡介

科學家夫妻創立 BioNTech ,​​開發 COVID-19 疫苗!


當在中國武漢發現COVID-19時,BioNTech 已部署尖端技術並創造世界上第一個臨床批准的新冠疫苗。

2019 年末,新冠病毒開始橫掃全球,
每天成千上萬人染疫,
救命任務迫在眉睫。

研究癌症免疫療法的BioNTech
憑藉對 mRNA 技術的信念,
在疫情爆發後,
以大膽的創意和精確的科學態度,
以不到一年的速度,
開發出劃時代的BNT疫苗。

《光速計畫》刻劃了這時代最重要的醫療里程碑:
BioNTech創辦人吳沙忻、圖雷西與團隊的救世意志,
新科技疫苗研發的科學進展、生技公司在商場及政治的合作協調,
得以讓 BNT 疫苗迅速問世,成為人類打贏這場戰疫的後盾。

吳沙忻在(2020 年)1月24日就明白了這場全球大流行的規模。我遠不及他的速度。
—— 前任德國總理,梅克爾(Angela Merkel)

吳沙忻與圖雷西,是繼居禮夫婦發現放射性後,最被頌揚的科學夫婦。
—— 倫敦《泰唔士報》

這是一本關於醫學壯舉的傑出報導。
—— 《科克斯書評》(Kirkus)

本中文書介出自《光速計畫: BioNTech疫苗研發之路》遠見天下文化出版股份有限公司出版


Winners of the Paul Ehrlich Prize

The dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19.

Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world’s first clinically approved inoculation for the coronavirus.

The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time.

Written by Joe Miller—the Financial Times’ Frankfurt correspondent who covered BioNTech’s COVID-19 project in real time—with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic.
"
展開看更多

作者介紹

Joe Miller

Joe Miller is the Frankfurt correspondent for Financial Times. He previously reported for BBC News in London, New York, Delhi, and Berlin.



Dr. Özlem Türeci

Dr. Özlem Türeci and Dr. Ugur Sahin are the husband-and-wife team that cofounded BioNTech, developers of the world’s first COVID-19 vaccine. The children of Turkish migrant workers in Germany, they trained as medical doctors and earned doctorates in molecular biology and immunotherapy. They have done extensive work in the field of translational oncology and written hundreds of scientific papers and patents.



Dr. Ugur Sahin

Dr. Ugur Sahin and Dr. Özlem Türeci are the husband-and-wife team that cofounded BioNTech, developers of the world’s first COVID-19 vaccine. The children of Turkish migrant workers in Germany, they trained as medical doctors and earned doctorates in molecular biology and immunotherapy. They have done extensive work in the field of translational oncology and written hundreds of scientific papers and patents.

規格

誠品貨碼 / 2682055584001
ISBN13 / 9781250280367
ISBN10 / 1250280362
EAN貨碼 / 9781250280367
頁數 / 272
注音版 / 否
裝訂 / H:精裝
語言 / 3:英文
尺寸 / 23.5X15.5X0CM
級別 / N:無

退貨說明

退貨須知:

  1. 依照消費者保護法的規定,您享有商品貨到次日起七天猶豫期(含例假日)的權益(請注意!猶豫期非試用期),辦理退貨之商品必須是全新狀態(不得有刮傷、破損、受潮)且需完整(包含全部商品、配件、原廠內外包裝、贈品及所有附隨文件或資料的完整性等)。
  2. 請您以送貨廠商使用之包裝紙箱將退貨商品包裝妥當,若原紙箱已遺失,請另使用其他紙箱包覆於商品原廠包裝之外,切勿直接於原廠包裝上黏貼紙張或書寫文字。若原廠包裝損毀將可能被認定為已逾越檢查商品之必要程度,本公司得依毀損程度扣除回復原狀必要費用(整新費)後退費;請您先確認商品正確、外觀可接受,再行拆封,以免影響您的權利;若為產品瑕疵,本公司接受退貨。

依「通訊交易解除權合理例外情事適用準則」,下列商品不適用七日猶豫期,除產品本身有瑕疵外,不接受退貨:

  1. 易於腐敗、保存期限較短或解約時即將逾期。(如:生鮮蔬果、乳製品、冷凍冷藏食材、蛋糕)
  2. 依消費者要求所為之客製化給付。(如:客製印章、鋼筆刻字)
  3. 報紙、期刊或雜誌。
  4. 經消費者拆封之影音商品或電腦軟體。
  5. 非以有形媒介提供之數位內容或一經提供即為完成之線上服務,經消費者事先同意始提供。(如:電子書)
  6. 已拆封之個人衛生用品。(如:內衣褲、襪類、褲襪、刮鬍刀、除毛刀等貼身用品)
  7. 國際航空客運服務。

若您退貨時有下列情形,可能被認定已逾越檢查商品之必要程度而須負擔為回復原狀必要費用(整新費),或影響您的退貨權利,請您在拆封前決定是否要退貨:

  1. 以數位或電磁紀錄形式儲存或著作權相關之商品(包含但不限於CD、VCD、DVD、電腦軟體等) 包裝已拆封者(除運送用之包裝以外)。
  2. 耗材(包含但不限於墨水匣、碳粉匣、紙張、筆類墨水、清潔劑補充包等)之商品包裝已拆封者(除運送用之包裝以外)。
  3. 衣飾鞋類/寢具/織品(包含但不限於衣褲、鞋子、襪子、泳裝、床單、被套、填充玩具)或之商品缺件(含購買商品、附件、內外包裝、贈品等)或經剪標或下水或商品有不可回復之髒污或磨損痕跡。
  4. 食品、美容/保養用品、內衣褲等消耗性或個人衛生用品、商品銷售頁面上特別載明之商品已拆封者(除運送用之包裝外一切包裝、包括但不限於瓶蓋、封口、封膜等接觸商品內容之包裝部分)或已非全新狀態(外觀有刮傷、破損、受潮等)與包裝不完整(缺少商品、附件、原廠外盒、保護袋、配件紙箱、保麗龍、隨貨文件、贈品等)。
  5. 家電、3C、畫作、電子閱讀器等商品,除商品本身有瑕疵外,退回之商品已拆封(除運送用之包裝外一切包裝、包括但不限於封膜等接觸商品內容之包裝部分、移除封條、拆除吊牌、拆除貼膠或標籤等情形)或已非全新狀態(外觀有刮傷、破損、受潮等)與包裝不完整(缺少商品、附件、原廠外盒、保護袋、配件紙箱、保麗龍、隨貨文件、贈品等)。
  6. 退貨程序請參閱【客服專區→常見問題→誠品線上退貨退款】之說明。
付款/配送